Cervical Cancer News and Research

RSS

Cancer is a disease in which cells in the body grow out of control. Cancer is always named for the part of the body where it starts, even if it spreads to other body parts later. When cancer starts in the cervix, it is called cervical cancer. The cervix is the lower, narrow end of the uterus. Also known as the womb, the uterus is where a baby grows when a woman is pregnant. The cervix connects the upper part of the uterus to the vagina (birth canal).

Cervical cancer is highly preventable in most Western countries because screening tests and a vaccine to prevent HPV infections are available. When cervical cancer is found early, it is highly treatable and associated with long survival and good quality of life.

WHO and FIND join forces to accelerate diagnostic innovation and access

FIND and the World Health Organization (WHO) have signed a new Memorandum of Understanding (MoU) that lays the foundation for accelerating innovation and achieving equitable access to quality diagnostics for people globally.

8 Jun 2024

Canada's plan to eliminate cervical cancer by 2040: HPV-based screening and vaccination key

The impact of three priority actions of the Canadian Partnership Against Cancer (CPAC) on the time to eliminate cervical cancer in British Columbia (BC), Canada.

5 Jun 2024

Researchers develop a simpler and more effective screening method for cervical cancer

Researchers at Karolinska Institutet in Sweden and the University of Innsbruck in Austria have developed a simpler and more effective screening method for cervical cancer than the method used today.

4 Jun 2024

HPV-based screening key to eliminating cervical cancer in Canada

Implementing human papillomavirus (HPV)-based screening in British Columbia could eliminate cervical cancer in the province before 2040, according to a modeling study in CMAJ.

3 Jun 2024

Surface-enhanced raman spectroscopy for precise diagnosis of infections

Every year, medical diagnostics are getting better and better thanks to the tremendous development of new methods that enable the precise detection of the many different molecules present in biological fluids during an infection.

29 May 2024

Study links diverse Gardnerella species in pregnant women to higher preterm birth risk

Researchers investigated the diversity of Gardnerella species in the vaginal microbiomes of pregnant women, finding an association between higher Gardnerella richness and increased risk of preterm delivery.

26 May 2024

Study shows safety of extended HPV testing intervals in cervical cancer screening

The risk of detecting cervical precancer eight years after a negative human papillomavirus (HPV) screening was found to be similar to the risk after three years (the commonly recommended screening interval) after a negative cytology screening.

22 May 2024

Aptamer and Timser partner to deliver world’s first blood test for cervical cancer

Aptamer Group plc (AIM: APTA), the developer of novel Optimer® binders to enable innovation in the life sciences industry, has signed an agreement with Timser Group, a pharmaceutical company focused on women’s health, with a deal value of up to £465,000.

From Aptamer Group 22 May 2024

HPV vaccination reduces cervical cancer across all socioeconomic groups in England

The human papillomavirus (HPV) vaccination programme in England has not only been associated with a substantial reduction in cervical disease, but has done so in all socioeconomic groups, finds a study published by The BMJ today.

16 May 2024

Cervical cancer rates drop significantly among vaccinated women

The efficiency of the HPV vaccination program in reducing the prevalence of cervical cancers.

16 May 2024

FDA-approved TIVDAK®: Targeting tissue factor in cervical cancer

On April 29th, 2024, the U.S. FDA granted full approval for Seagen Inc.'s TIVDAK® (tisotumab vedotin) targeting tissue factor (TF) for the treatment of patients with recurrent or metastatic cervical cancer who have progressed on or after chemotherapy. This marks a significant advancement in the therapeutic landscape for cervical cancer, highlighting the potential of antibody-drug conjugates (ADCs) in oncology.

From Sino Biological Inc. 10 May 2024

Understanding cancer cell behavior: Cellular contractility modes and tumor aggressiveness

Understanding how cancerous cells spread from a primary tumor is important for any number of reasons, including determining the aggressiveness of the disease itself.

7 May 2024

Novel vaccine approach targets AML and other blood cancers

Acute myeloid leukemia (AML) is a type of blood cancer that forms in the soft marrow of the bones, typically attacking cells that would otherwise form the key component of the body's immunodefense system, white blood cells.

3 May 2024

New Kaposi sarcoma mouse model could be key to drug development

Researchers at UNC Lineberger Comprehensive Cancer Center, after decades of research efforts, have developed a mouse model of Kaposi sarcoma that could be key to the development of new drugs to treat the disease.

29 Apr 2024

Study finds major gaps in cancer screening use in Federally Qualified Health Centers

A national study led by researchers at The University of Texas MD Anderson Cancer Center and The University of New Mexico (UNM) Comprehensive Cancer Center found major gaps in breast, cervical and colorectal cancer screening use in Federally Qualified Health Centers (FQHCs) in the U.S., relative to overall screening rates in the country.

29 Apr 2024

Cervical Cancer News and Research

Further Reading

WHO and FIND join forces to accelerate diagnostic innovation and access

Canada's plan to eliminate cervical cancer by 2040: HPV-based screening and vaccination key

Researchers develop a simpler and more effective screening method for cervical cancer

HPV-based screening key to eliminating cervical cancer in Canada

Surface-enhanced raman spectroscopy for precise diagnosis of infections

Study links diverse Gardnerella species in pregnant women to higher preterm birth risk

Study shows safety of extended HPV testing intervals in cervical cancer screening

Aptamer and Timser partner to deliver world’s first blood test for cervical cancer

HPV vaccination reduces cervical cancer across all socioeconomic groups in England

Cervical cancer rates drop significantly among vaccinated women

FDA-approved TIVDAK®: Targeting tissue factor in cervical cancer

Understanding cancer cell behavior: Cellular contractility modes and tumor aggressiveness

Novel vaccine approach targets AML and other blood cancers

New Kaposi sarcoma mouse model could be key to drug development

Study finds major gaps in cancer screening use in Federally Qualified Health Centers

154 million lives saved: Landmark study highlights power of vaccination

Urine-based test developed for early detection of head and neck tumors

New genetic variants could raise a woman's risk of cervical cancer from HPV infections

Study explores factors contributing to rural-urban difference in cervical cancer screening

Major global commitments announced to eradicate cervical cancer

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Latest News